Tilray Stock News

And why it''s pulling up Canopy Growth and Tilray marijuana stocks alongside it.

Below is a recap of the main news related to the cannabis industry and markets for the week of February 7, 2022. Contents Schumer Urges Senators To Help Finalize Marijuana Legalization Bill No Weed At The Super Bowl Canopy Growth’s Quarterly Results And Analyst Reactions Leafly’s Nasdaq Debut Hexo Cuts 180 Jobs Increased THC Percentage In Hemp Products Sought Under New Congressional Bill Markets M&A Financings Earnings Reports Tilray Consolidates Its Portfolio Sundial Growers Granted 180-Day Extension By NASDAQ Top Stories Of The Week Schumer Urges Senators To Help Finalize Marijuana Legalization Bill Senate Majority Leader Charles Schumer (D-N.Y.), Finance Committee Chairman Ron Wyden (D-Ore.) and Sen. Cory Booker (D-N.J.) asked senators to help them complete the marijuana legalization bill expected to be filed in April . To that end, the top Senate Democrats sent letters to their colleagues encouraging them to get into the drafting process and help finalize this legislation. The letter comes nearly a week after Schumer told a press conference in New York City, that in April he plans to officially file the long-awaited bill to federally legalize cannabis . “In the coming weeks, we’re ramping up our outreach—and we expect to introduce final legislation.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cannabis stocks are up today as some companies report earnings. Sundial Growers has its own cause to celebrate as its story continues. The post Cannabis Stocks Alert: Why Are SNDL, CGC, TLRY, ACB Stocks Are Getting High Today? appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First…

Tilray … Full story available on Benzinga.com

SweetWater Brewing Company, LLC, a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY ) (TSX:TLRY), announced its landmark expansion across the state of California with distribution partners, Reyes Beer Division . This ties together the continued westward expansion of the SweetWater brand with the opening of SweetWater Colorado Brewing Company, LLC in Fort Collins , Colorado, and t he recent acquisition of San Diego beer brands, Alpine Beer Company and Green Flash Brewing Company. With this expansion, the nation''s 11th largest craft brewer will now be available for purchase throughout the state at local restaurants, bars, grocery chains, Full story available on Benzinga.com

Tilray Inc. said Tuesday it created its new Tilray Medical unit by combining the medical divisions of Tilray and Aphria. The move comes after Tilray acquired Aphria in May, 2021. "By unifying the global medical divisions of Tilray and Aphria under a cohesive strategy and mission, Tilray Medical emerges as the premier global supplier of a portfolio of high-quality, effective medical cannabis brands and products for patients in need around the world," said Denise Faltischek, head of international and chief strategy officer at Tilray. Shares of Tilray are down by 14% so far in 2022, compared to a dip of 10.4% by the Nasdaq. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

Tilray Brands, Inc. (NASDAQ: TLRY ) (TSX:TLRY) announced the launch of Tilray Medical, a global medical platform that consolidates the its medical cannabis brands under one strategy, mission, and vision, Financial Post writes. “Tilray is the global leader in the advancement of cannabinoid-based medicine, with a focus on providing research-backed medical cannabis products to physicians, pharmacies, and … Full story available on Benzinga.com

Canopy Growth Corporation (NASDAQ: CGC ) and Tilray, Inc (NASDAQ: TLRY ) soared 10.59% and 8.76%, respectively, on Monday. The overall sector has been all but demolished since the high times of 2018, when Canada legalized cannabis at the federal level, and the beginning of 2021, when President Joe Bidens inauguration led many to believe federal legalization in the U.S. may be on the horizon. Canopy Growth Corporation has plummeted 86% from its Oct. 16, 2018 all-time high of $59.25, while Tilray has plunged about 98% from its Sept. 19, 2018 all-time high of $300. Although the stocks shot up again in February 2021, with Canopy Growth reaching a high of $56.50 and Tilray soaring up to the $67 level on Feb. 10, the sector has failed to sustain any long-term bull cycle. If neither a continued bounce nor bull cycle takes place, the stocks are beginning to show some characteristics that could make them candidates for a short squeeze. Canopy Growth comes in as a better candidate for a squeeze, with 18.13% of its float held short compared to Tilray, which has 13.16% of its float held short.

Cannara’s Valleyfield Facility This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. In the fall of 2018, Canada became the second country in the world to legalize the recreational use of marijuana . Since that time the Canadian cannabis industry has grown dramatically. Last year saw revenues top $3 billion, and that number is expected to double by 2026, according to Statista.com. These massive revenues have been driven by first movers in the Canadian market like Tilray Inc. (NASDAQ: TLRY ), Canopy Growth Corp. (NASDAQ: CGC ), and Cronos Group Inc. (NASDAQ: CRON ). These producers represent what … Full story available on Benzinga.com

InvestorPlace - Stock Market News, Stock Advice & Trading Tips TLRY stock is off the investor radar and nearing zero fast. Since its business is improving, eventually it will regain its fans. The post Tilray Stock Has Gone up in Smoke But Odds Are Good appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2 Says Buy THIS Now Man Who Called Black Monday: Prepare Now. #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First

Tilray Inc - Class 2 (TLRY) shares closed today at 0.4% above its 52 week low of $5.20, giving the company a market cap of $2B. The stock is currently down 20.9% year-to-date, down 70.8% over the past 12 months, and down 75.2% over the past five years. This week, the Dow Jones Industrial Average fell 2.5%, and the S&P 500 fell 4.1%. Trading Activity Trading volume this week was 26.4% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 2.2. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Materials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 24.2% The company's stock price performance over the past 12 months lags the peer average by 122.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Tilray Brands (TLRY) announces the expansion of its medical cannabis product offering in Australia and a new medical cannabis e-learning platform for healthcare providers

New Tilray Branded and GMP-Certified 15g Medical Cannabis Whole Flower Now Available for Patients Under Australia''s TGA Special Access and Authorized Prescriber Scheme Company Launches Online Medical Cannabis Education Platform for Healthcare Professions in Australia and New Zealand NEW YORK and SYDNEY, Australia, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ: TLRY , TSX: TLRY ), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today announced the expansion of its medical cannabis product offering in Australia and a new medical cannabis e-learning platform for healthcare providers. Denise Faltischek, Head of International and Chief Strategy Officer, said, "Tilray is transforming the industry globally with our highly scalable footprint and portfolio of diverse cannabis products. As medical cannabis demand increases worldwide, we remain committed to providing healthcare professionals and patients with safe and reliable access to the highest-quality medical cannabis products." Ms.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Tilray has high costs to overcome first as it builds its brand recognition in the U.S. market and ahead of the Federal cannabis legalization. The post Why TLRY Stock Is at a Positive Turning Point appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2 Says Buy THIS Now Man Who Called Black Monday: Prepare Now. #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First